Improving medication treatment leads to dramatic gains in emergency department care for opioid use disorder

What makes an mRNA vaccine so effective against severe COVID-19?
23 December 2021
Efficacy of bamlanivimab for COVID-19 may vary with antibody status
23 December 2021

Improving medication treatment leads to dramatic gains in emergency department care for opioid use disorder

A program designed to increase initiation of buprenorphine treatment for opioid use disorder in the emergency department led to a sixfold increase in its use at three Penn Medicine hospitals, according to new research from the Perelman School of Medicine at the University of Pennsylvania. By using various tactics in three acute care centers—ranging from financial incentives for doctors to train to treat opioid use disorder to an automated connection to peer recovery specialists—the program was not only able to boost buprenorphine treatment rates initially, but it sustained the changes.

Comments are closed.